Cooley Advised Investor Syndicate on $2.25 Billion Acquisition of HistoSonics

Cooley Advised Investor Syndicate on $2.25 Billion Acquisition of HistoSonics

Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.

The investor syndicate includes K5 Global, Bezos Expeditions, Wellington Management, top-tier global investment firms such as Alpha JWC Ventures, and existing investors Alpha Wave Ventures, Venture Investors Health Fund, Lumira Ventures, Hatteras Venture Partners, Early Stage Partners, Amzak Health, HealthQuest Capital, Yonjin Venture, the State of Wisconsin Investment Board, the State of Michigan Retirement System, and Johnson & Johnson Innovation JJDC, among others.

The Cooley team advising the investor syndicate was led by Patrick Loofbourrow, Bram Couvreur, Rama Padmanabhan, Jenny Ge, Nick Kenyon, Josh Himmelstern, and Joanna Zhang.

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.